Related references
Note: Only part of the references are listed.Progress in immune-based therapies for type 1 diabetes
M. von Herrath et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Mesenchymal stem cells in tissue repair
Amy M. DiMarino et al.
FRONTIERS IN IMMUNOLOGY (2013)
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
Lena von Bahr et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Fall in C-Peptide During First 2 Years From Diagnosis Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes Trial Net Data
Carla J. Greenbaum et al.
DIABETES (2012)
Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study
D. Dabelea et al.
DIABETOLOGIA (2012)
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Guido Moll et al.
STEM CELLS (2012)
Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
L. von Bahr et al.
STEM CELLS (2012)
Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes
Mollie Jurewicz et al.
DIABETES (2010)
Mesenchymal Stem Cells Inhibit Human Th17 Cell Differentiation and Function and Induce a T Regulatory Cell Phenotype
Soufiane Ghannam et al.
JOURNAL OF IMMUNOLOGY (2010)
Persistent High Glucose Concentrations Alter the Regenerative Potential of Mesenchymal Stem Cells
Christopher Cramer et al.
STEM CELLS AND DEVELOPMENT (2010)
Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and-9
Yunchuan Ding et al.
DIABETES (2009)
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
Paolo Fiorina et al.
JOURNAL OF IMMUNOLOGY (2009)
Immunomodulation by mesenchymal stem cells - A potential therapeutic strategy for type 1 diabetes
Reza Abdi et al.
DIABETES (2008)
Mesenchymal cells recruit and regulate T regulatory cells
Mauro Di Lanni et al.
EXPERIMENTAL HEMATOLOGY (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
The anti-inflammatory and anti-angiogenic role of mesenchymal stem cells in corneal wound healing following chemical injury
Joo Youn Oh et al.
STEM CELLS (2008)
Hnmunomodulatory properties of mesenchymal stromal cells
Alma J. Nauta et al.
BLOOD (2007)
A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells
Dominique Chabannes et al.
BLOOD (2007)
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Kazuya Sato et al.
BLOOD (2007)
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice
Ryang Hwa Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
International trial of the edmonton protocol for islet transplantation
A. M. James Shapiro et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
K Le Blanc et al.
LANCET (2004)
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation
R Meisel et al.
BLOOD (2004)
β-cell function and the development of diabetes-related complications in the diabetes control and complications trial
MW Steffes et al.
DIABETES CARE (2003)
Share Paper
